Perform Another (Advanced) Search

1.  CenterWatch: Clinical Trials in Category (37) Skin Cancer
...Inc. Phase II Study in Patients With Untreated Unresectable Stage II or IV Melanoma Receiving Dacarbazine and Ipilimumab (MDX-010) vs. Dacarbazine With Placebo Burbank : East Valley Hematology And Oncology Medical Group Phase II Study in Patients ...
View Page

2.  Study Posting (1570) Trial #156560, Melanoma, Morristown, NJ
...Study Posting (1570) Trial #156560, Melanoma, Morristown, NJ Trial Information Trial of Dacarbazine With or Without Genasense in Advanced Melanoma (AGENDA) This study is being performed to prospectively determine whether dacarbazine plus Genasense is significantly better than dacarbazine plus placebo in chemotherapy-naive patients with advanced ...
View Page

3.  Study Posting (1570) Trial #156565, Melanoma, Morristown, NJ
...Posting (1570) Trial #156565, Melanoma, Morristown, NJ Trial Information A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma The main purpose of this research study ...
...compare the safety, tolerability, and anti tumor activity of an investigational drug, ABI-007 versus Dacarbazine in patients with metastatic melanoma who have not previously received chemotherapy. ABI-007 is a ...
View Page

4.  Study Posting (4422) Trial #109439, Skin Cancer, Wirral, United Kingdom
...Information Phase II Study in Patients With Untreated Unresectable Stage II or IV Melanoma Receiving Dacarbazine and Ipilimumab (MDX-010) vs. Dacarbazine With Placebo The purpose of this clinical research study is to examine the safety and ...
View Page

5.  Study Posting (4422) Trial #109438, Skin Cancer, London, United Kingdom
...Information Phase II Study in Patients With Untreated Unresectable Stage II or IV Melanoma Receiving Dacarbazine and Ipilimumab (MDX-010) vs. Dacarbazine With Placebo The purpose of this clinical research study is to examine the safety and ...
View Page

6.  Study Posting (4422) Trial #109434, Skin Cancer, Uzhgorod, Ukraine
...Information Phase II Study in Patients With Untreated Unresectable Stage II or IV Melanoma Receiving Dacarbazine and Ipilimumab (MDX-010) vs. Dacarbazine With Placebo The purpose of this clinical research study is to examine the safety and ...
View Page

7.  Study Posting (4422) Trial #109436, Skin Cancer, Lviv, Ukraine
...Information Phase II Study in Patients With Untreated Unresectable Stage II or IV Melanoma Receiving Dacarbazine and Ipilimumab (MDX-010) vs. Dacarbazine With Placebo The purpose of this clinical research study is to examine the safety and ...
View Page

8.  Study Posting (4422) Trial #109435, Skin Cancer, Kiev, Ukraine
...Information Phase II Study in Patients With Untreated Unresectable Stage II or IV Melanoma Receiving Dacarbazine and Ipilimumab (MDX-010) vs. Dacarbazine With Placebo The purpose of this clinical research study is to examine the safety and ...
View Page

9.  Study Posting (4422) Trial #109433, Skin Cancer, Dnepropetrovsk, Ukraine
...Information Phase II Study in Patients With Untreated Unresectable Stage II or IV Melanoma Receiving Dacarbazine and Ipilimumab (MDX-010) vs. Dacarbazine With Placebo The purpose of this clinical research study is to examine the safety and ...
View Page

10.  Study Posting (4422) Trial #109437, Skin Cancer, Cherkassy, Ukraine
...Information Phase II Study in Patients With Untreated Unresectable Stage II or IV Melanoma Receiving Dacarbazine and Ipilimumab (MDX-010) vs. Dacarbazine With Placebo The purpose of this clinical research study is to examine the safety and ...
View Page

11.  Study Posting (4422) Trial #109429, Skin Cancer, Zaragoza, Spain
...Information Phase II Study in Patients With Untreated Unresectable Stage II or IV Melanoma Receiving Dacarbazine and Ipilimumab (MDX-010) vs. Dacarbazine With Placebo The purpose of this clinical research study is to examine the safety and ...
View Page

12.  Study Posting (4422) Trial #109432, Skin Cancer, Valencia, Spain
...Information Phase II Study in Patients With Untreated Unresectable Stage II or IV Melanoma Receiving Dacarbazine and Ipilimumab (MDX-010) vs. Dacarbazine With Placebo The purpose of this clinical research study is to examine the safety and ...
View Page

13.  Study Posting (4422) Trial #109430, Skin Cancer, Malaga, Spain
...Information Phase II Study in Patients With Untreated Unresectable Stage II or IV Melanoma Receiving Dacarbazine and Ipilimumab (MDX-010) vs. Dacarbazine With Placebo The purpose of this clinical research study is to examine the safety and ...
View Page

14.  Study Posting (4422) Trial #109431, Skin Cancer, Canarias, Spain
...Information Phase II Study in Patients With Untreated Unresectable Stage II or IV Melanoma Receiving Dacarbazine and Ipilimumab (MDX-010) vs. Dacarbazine With Placebo The purpose of this clinical research study is to examine the safety and ...
View Page

15.  Study Posting (4422) Trial #109426, Skin Cancer, Saxonwold, South Africa
...Information Phase II Study in Patients With Untreated Unresectable Stage II or IV Melanoma Receiving Dacarbazine and Ipilimumab (MDX-010) vs. Dacarbazine With Placebo The purpose of this clinical research study is to examine the safety and ...
View Page

16.  Study Posting (4422) Trial #109425, Skin Cancer, Pretoria, South Africa
...Information Phase II Study in Patients With Untreated Unresectable Stage II or IV Melanoma Receiving Dacarbazine and Ipilimumab (MDX-010) vs. Dacarbazine With Placebo The purpose of this clinical research study is to examine the safety and ...
View Page

17.  Study Posting (4422) Trial #109427, Skin Cancer, Port Elizabeth, South Africa
...Information Phase II Study in Patients With Untreated Unresectable Stage II or IV Melanoma Receiving Dacarbazine and Ipilimumab (MDX-010) vs. Dacarbazine With Placebo The purpose of this clinical research study is to examine the safety and ...
View Page

18.  Study Posting (4422) Trial #109428, Skin Cancer, Panorama, South Africa
...Information Phase II Study in Patients With Untreated Unresectable Stage II or IV Melanoma Receiving Dacarbazine and Ipilimumab (MDX-010) vs. Dacarbazine With Placebo The purpose of this clinical research study is to examine the safety and ...
View Page

19.  Study Posting (4422) Trial #109424, Skin Cancer, Johannesburg, South Africa
...Information Phase II Study in Patients With Untreated Unresectable Stage II or IV Melanoma Receiving Dacarbazine and Ipilimumab (MDX-010) vs. Dacarbazine With Placebo The purpose of this clinical research study is to examine the safety and ...
View Page

20.  Study Posting (4422) Trial #109419, Skin Cancer, Voronezh, Russian Federation
...Information Phase II Study in Patients With Untreated Unresectable Stage II or IV Melanoma Receiving Dacarbazine and Ipilimumab (MDX-010) vs. Dacarbazine With Placebo The purpose of this clinical research study is to examine the safety and ...
View Page